drugset / Trial / NCT04591847

Pregnancy Outcome and Vitamin D Level Among Vitamin D Supplementation During Pregnancy

NCT04591847

RandomizedParallel-groupQuadruple-blindPrevention

Summary

To compared pregnancy outcome (Serum vitamin D level in mother and infant , preeclampsia rate, preterm birth rate, Infant birth weight, Infant length , APGAR score) between pregnant women who were given vitamin D supplementation and pregnant women who were given placebo

Timeline

Start
2020-10-19
Primary completion
2021-07-31
Completion
2021-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ergocalciferol Small molecule 20000 iu Oral

Indications

No indication recorded.